DEA issues dire warning on fentanyl mixed with flesh-eating ‘Tranq’ zombie drug seized in 48 of 50 states
The U.S. Drug Enforcement Administration (DEA), issued a warning about fentanyl and a flesh-eating “Tranq,” zombie drug. It has been seized in 48 of 50 states.
The DEA issued a new safety alert warning Americans about a sharp rise in the supply of fentanyl and xylazine. Veterinary use of xylazine (also known as Tranq) is approved by the U.S. Food and Drug Administration.
Anne Milgram, DEA administrator, stated that xylazine poses the most serious drug threat to our country, making fentanyl even more deadly. “DEA has seized xylazine, fentanyl combinations in 48 of the 50 States. According to the DEA Laboratory System, approximately 23% and 7% of fentanyl powder seized by DEA were xylazine-containing pills.
The alert states that xylazine/fentanyl drug combinations put users at higher risk for fatal drug poisoning. Naloxone (Narcan), which is an opioid, does not reverse the effects of xylazine.
The alert stated that experts recommend administering Naloxone to anyone who might be suffering from drug poisoning. People who inject drug combinations containing xylazine can also develop severe wounds. This includes necrosis, which is the rotting and destruction of human tissue. It could lead to anamputation.
The U.S. Centers for Disease Control and Prevention reported that 107,735 Americans died from drug poisonings between August 2021 and 2022. 66% of those deaths were caused by synthetic opioids such as fentanyl.
The DEA alert stated that the majority of the fentanyl being trafficked in the United States is coming from Mexico by the Sinaloa Cartel or Jalisco Cartel, both largely sourced in China.
Recently, the FDA informed health care providers of the potential dangers to patients who are exposed to xylazine from illicit drugs. The FDA stated that xylazine is not safe to use in humans. It may cause serious and potentially life-threatening side effects similar to opioid addiction. This makes it difficult to differentiate opioid overdoses and xylazine.
Routine toxicology screenings do not detect xylazine. Health care professionals are encouraged to examine patients for signs and symptoms, including severe, necrotic, skin ulcerations.
Fox News Digital was contacted by a Philadelphia businessman and former drug addict to learn how “Tranq dope,” bags of the drug, were selling for as low as $4 per pop. He described what it was like walking through a group of three or four people strung out along the streets, and how they smelled of “rotting flesh” due to open sores.
Substance Use Philly reports that Xylazine was detected in more than 90% of Philadelphia drug samples in 2021.